silicon and Osteoporosis

silicon has been researched along with Osteoporosis* in 20 studies

Reviews

3 review(s) available for silicon and Osteoporosis

ArticleYear
Do Only Calcium and Vitamin D Matter? Micronutrients in the Diet of Inflammatory Bowel Diseases Patients and the Risk of Osteoporosis.
    Nutrients, 2021, Feb-05, Volume: 13, Issue:2

    Osteoporosis is one of the most common extraintestinal complications among patients suffering from inflammatory bowel diseases. The role of vitamin D and calcium in the prevention of a decreased bone mineral density is well known, although other nutrients, including micronutrients, are also of extreme importance. Despite the fact that zinc, copper, selenium, iron, cadmium, silicon and fluorine have not been frequently discussed with regard to the prevention of osteoporosis, it is possible that a deficiency or excess of the abovementioned elements may affect bone mineralization. Additionally, the risk of malnutrition, which is common in patients with ulcerative colitis or Crohn's disease, as well as the composition of gut microbiota, may be associated with micronutrients status.

    Topics: Bone Density; Cadmium; Calcium; Colitis, Ulcerative; Copper; Crohn Disease; Female; Fluorine; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Iron Deficiencies; Iron Overload; Male; Malnutrition; Micronutrients; Osteoporosis; Risk Factors; Selenium; Silicon; Vitamin D; Zinc

2021
A review of the effects of dietary silicon intake on bone homeostasis and regeneration.
    The journal of nutrition, health & aging, 2014, Volume: 18, Issue:9

    Increasing evidences suggest that dietary Silicon (Si) intake, is positively correlated with bone homeostasis and regeneration, representing a potential and valid support for the prevention and improvement of bone diseases, like osteoporosis. This review, aims to provide the state of art of the studies performed until today, in order to investigate and clarify the beneficial properties and effects of silicates, on bone metabolism.. We conducted a systematic literature search up to March 2013, using two medical databases (Pubmed and the Cochrane Library), to review the studies about Si consumption and bone metabolism.. We found 45 articles, but 38 were specifically focused on Si studies.. RESULTS showed a positive relationship between dietary Si intake and bone regeneration.

    Topics: Animals; Bone and Bones; Bone Regeneration; Cell Line; Diet; Female; Homeostasis; Humans; Mice; Models, Animal; Osteoporosis; Silicon

2014
Bio-silica and bio-polyphosphate: applications in biomedicine (bone formation).
    Current opinion in biotechnology, 2012, Volume: 23, Issue:4

    Bio-silica represents the main mineral component of the sponge skeletal elements (siliceous spicules), while bio-polyphosphate (bio-polyP), a multifunctional polymer existing in microorganisms and animals acts, among others, as reinforcement for pores in cell membranes. These natural inorganic bio-polymers, which can be readily prepared, either by recombinant enzymes (bio-silica and bio-polyP) or chemically (polyP), are promising materials/substances for the amelioration and/or treatment of human bone diseases and dysfunctions. It has been demonstrated that bio-silica causes in vitro a differential effect on the expression of the genes OPG and RANKL, encoding two mediators that control the tuned interaction of the anabolic (osteoblasts) and catabolic (osteoclasts) pathways in human bone cells. Since bio-silica and bio-polyP also induce the expression of the key mediator BMP2 which directs the differentiation of bone-forming progenitor cells to mature osteoblasts and in parallel inhibits the function of osteoclasts, they are promising candidates for treatment of osteoporosis.

    Topics: Animals; Bone Diseases; Humans; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Phosphates; Porifera; Silicon; Silicon Dioxide

2012

Other Studies

17 other study(ies) available for silicon and Osteoporosis

ArticleYear
Ortho-silicic Acid Plays a Protective Role in Glucocorticoid-Induced Osteoporosis via the Akt/Bad Signal Pathway In Vitro and In Vivo.
    Biological trace element research, 2023, Volume: 201, Issue:2

    Glucocorticoid-induced osteoporosis (GIOP) has been the most common form of secondary osteoporosis. Glucocorticoids (GCs) can induce osteocyte and osteoblast apoptosis. Plenty of research has verified that silicon intake would positively affect bone. However, the effects of silicon on GIOP are not investigated. In this study, we assessed the impact of ortho-silicic acid (OSA) on Dex-induced apoptosis of osteocytes by cell apoptosis assays. The apoptosis-related genes, cleaved-caspase-3, Bcl-2, and Bax, were detected by western blotting. Then, we evaluated the possible role of OSA on osteogenesis and osteoclastogenesis with Dex using Alizarin red staining and tartrate-resistant acid phosphatase (TRAP) staining. We also detected the related genes by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and western blotting. We then established the GIOP mouse model to evaluate the potential role of OSA in vivo. We found that OSA showed no cytotoxic on osteocytes below 50 μM and prevented MLO-Y4 from Dex-induced apoptosis. We also found that OSA promoted osteogenesis and inhibited osteoclastogenesis with Dex. OSA had a protective effect on GIOP mice via the Akt signal pathway in vivo. In the end, we verified the Akt/Bad signal pathway in vitro, which showed the same results. Our finding demonstrated that OSA could protect osteocytes from apoptosis induced by GCs both in vitro and in vivo. Also, it promoted osteogenesis and inhibited osteoclastogenesis with the exitance of Dex. In conclusion, OSA has the potential value as a therapeutic agent for GIOP.

    Topics: Animals; Dexamethasone; Glucocorticoids; Mice; Osteoblasts; Osteogenesis; Osteoporosis; Proto-Oncogene Proteins c-akt; Signal Transduction; Silicic Acid; Silicon

2023
Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep.
    Acta biomaterialia, 2020, 01-01, Volume: 101

    Silicon-substituted hydroxyapatite (SiHA) macroporous scaffolds have been prepared by robocasting. In order to optimize their bone regeneration properties, we have manufactured these scaffolds presenting different microstructures: nanocrystalline and crystalline. Moreover, their surfaces have been decorated with vascular endothelial growth factor (VEGF) to evaluate the potential coupling between vascularization and bone regeneration. In vitro cell culture tests evidence that nanocrystalline SiHA hinders pre-osteblast proliferation, whereas the presence of VEGF enhances the biological functions of both endothelial cells and pre-osteoblasts. The bone regeneration capability has been evaluated using an osteoporotic sheep model. In vivo observations strongly correlate with in vitro cell culture tests. Those scaffolds made of nanocrystalline SiHA were colonized by fibrous tissue, promoted inflammatory response and fostered osteoclast recruitment. These observations discard nanocystalline SiHA as a suitable material for bone regeneration purposes. On the contrary, those scaffolds made of crystalline SiHA and decorated with VEGF exhibited bone regeneration properties, with high ossification degree, thicker trabeculae and higher presence of osteoblasts and blood vessels. Considering these results, macroporous scaffolds made of SiHA and decorated with VEGF are suitable bone grafts for regeneration purposes, even in adverse pathological scenarios such as osteoporosis. STATEMENT OF SIGNIFICANCE: For the first time, the in vivo behavior of scaffolds made of silicon substituted hydroxyapatites (SiHA) has been evaluated under osteoporosis conditions. In order to optimize the bone regeneration properties of these bioceramics, 3D macroporous scaffolds have been manufactured by robocasting and implanted in osteoporotic sheep. Our experimental design shed light on the important issue of the biological response of nano-sized bioceramics vs highly crystalline bioceramics, as well as on the importance of coupling vascularization and bone growth processes by decorating SiHA scaffolds with vascular endothelial growth factor.

    Topics: Adsorption; Animals; Bone Regeneration; Cell Differentiation; Cell Line; Cell Proliferation; Cell Shape; Durapatite; Endothelial Cells; Female; Mice; Nanoparticles; Osteoblasts; Osteoporosis; Porosity; Sheep; Silicon; Swine; Tissue Scaffolds; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A

2020
Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio.
    Biological trace element research, 2019, Volume: 188, Issue:2

    We have reported that genistein (Gen) and silicon (Si) have synergistic effects on ovariectomy-induced bone loss in rat; however, the potential mechanisms behind this effect were not fully clarified yet. This study was performed to evaluate the bone protective mechanisms of concomitant intake of genistein and silicon in ovariectomized rat by OPG/RANKL axis. Three-month-old Sprague-Dawley female rats were subjected to ovariectomy (OVX) or sham surgery; after surgery, the OVX rats were randomly divided into five groups: OVX-Gen, OVX-Si, OVX-Gen-Si, OVX-E, and OVX. Genistein, silicon, and 17β-estradiol supplementation were started after ovariectomy and continued for 10 weeks. The results showed that genistein and silicon treatment increased the bone mineral density (BMD) of ovariectomized rats. In addition, the BMD of the tibia and femur were highest in the OVX-Gen-Si group compared with OVX-Gen and OVX-Si group (p < 0.05). After 10 weeks treatment with genistein and silicon, the bone structure of ovariectomized rats was recovered, there was no difference of bone histomorphometric parameters between OVX-Gen-Si, OVX-E, and SHAM group (p > 0.05), and there was no difference in the concentration of serum ALP, Ca, P, OPG, and RANKL between OVX-Gen-Si, SHAM, and OVX-E groups (p > 0.05). RT-PCR showed that genistein and silicon treatment could effectively increase the OPG mRNA expression and decreased the RANKL mRNA expression compared to that of the OVX group (p < 0.05), the OPG/RANKL mRNA ratios were significantly decreased in the OVX group (p < 0.05), and it was nearly to normal in the OVX-Gen-Si group. Immunohistochemical staining results showed that genistein and silicon supplementation could effectively increase the protein expression of OPG and decrease the protein expression of RANKL in bone tissues; there were no significant differences in OPG and RANKL positive expression areas between OVX-Gen-Si, SHAM, and OVX-E group (p > 0.05). The results above indicate that genistein and silicon supplementation can effectively reduce RANKL, increase OPG levels, and OPG/RANKL ratios in the serum and bone tissue of ovariectomized rats; this is the main mechanism by which genistein and silicon play a bone protective role in ovariectomized rats.

    Topics: Animals; Bone Density; Drug Synergism; Female; Femur; Genistein; Osteoporosis; Osteoprotegerin; Ovariectomy; Protective Agents; RANK Ligand; Rats, Sprague-Dawley; Silicon; Tibia

2019
Synergistic effect of Si-hydroxyapatite coating and VEGF adsorption on Ti6Al4V-ELI scaffolds for bone regeneration in an osteoporotic bone environment.
    Acta biomaterialia, 2019, 01-01, Volume: 83

    The osteogenic and angiogenic responses to metal macroporous scaffolds coated with silicon substituted hydroxyapatite (SiHA) and decorated with vascular endothelial growth factor (VEGF) have been evaluated in vitro and in vivo. Ti6Al4V-ELI scaffolds were prepared by electron beam melting and subsequently coated with Ca

    Topics: Alloys; Animals; Bone Regeneration; Cell Line; Cell Proliferation; Durapatite; Endothelial Cells; Female; Mice; Osteoblasts; Osteoporosis; Sheep; Silicon; Swine; Titanium; Vascular Endothelial Growth Factor A

2019
Gallium and silicon synergistically promote osseointegration of dental implant in patients with osteoporosis.
    Medical hypotheses, 2017, Volume: 103

    Over the last few decades, a wide variety of dental implants have been successfully placed in jaw bones to restore tooth function. But major challenges still remain in patients with osteoporosis involving compromised osseointegration, and the therapeutic methods is far from optimism. Gallium can directly inhibit bone osteolysis, prevent bone calcium release and augment bone mass, which makes Ga unique among the potential antiresorptive drugs. Silicon, as an indispensable modulator in bone formation, presents its bone anabolic effects, while reduces, at least doesn't increase, bone resorption. We hypothesize that the combination of bone anabolic effects of Si and antiresorptive effects of Ga will result in synergistic effects on the improvement of osteointegration under osteoporotic condition. In our strategy, in order to maximize the efficacy while minimize the side effects of ions, a novel titania mesoporous layer fabricated by electrochemical anodization on the surface of titanium implant will be employed as a promising local drug delivery system. The synergistic effects of Ga and Si on improving osseointegration will be verified by animal experiments, and be furthered by clinical trials. Our hypothesis could help to create an option to improve success rate of dental implants in osteoporotic patients.

    Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcium; Dental Implants; Gallium; Gene Expression Regulation; Humans; Models, Theoretical; Osseointegration; Osteogenesis; Osteoporosis; Rats; Silicon; Surface Properties; Titanium

2017
The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.
    Acta biomaterialia, 2017, 10-01, Volume: 61

    Bioactive ions released from bioceramics play important roles in bone regeneration; however, it is unclear how each ionic composition in complex bioceramics exerts its specific effect on bone regeneration. The aim of this study is to elucidate the functional effects of Sr and Si ions in bioceramics on the regeneration of osteoporotic bone. A model bioceramic with Sr- and Si-containing components (SMS) was successfully fabricated and the effects of ionic products from SMS bioceramics on the osteogenic, osteoclastic and angiogenic differentiation of rBMSCs-OVX and RANKL-induced osteoclasts were investigated. The results showed that SMS bioceramics could enhance ALP activity and expression of Col 1, OCN, Runx2, and angiogenic factors including VEGF and Ang-1. SMS bioceramics not only rebalanced the OPG/RANKL ratio of rBMSCs-OVX at early stage, but also repressed RANKL-induced osteoclast formation and expression of TRAP, DC-STAMP, V-ATPase a3, and NFATc1. The synergistic effects of Sr and Si ions were further investigated as compared with those of similar concentrations of Sr and Si ions alone. Sr and Si ions possessed synergistic effects on osteogenesis, osteoclastogenesis, and angiogenesis, attributed to the dominant effects of Sr ions on enhancing angiogenesis and repressing osteoclastogenesis, and the dominant effects of Si ions on stimulating osteogenesis. The in vivo study using critical-size mandibular defects of OVX rat models showed that SMS bioceramics could significantly enhance bone formation and mineralization compared with β-TCP bioceramics. Our results are the first to elucidate the specific effect of each ion from bioceramics on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration, paving the way for the design of functional biomaterials with complex compositions for tissue engineering and regenerative medicine.. Bioactive ions released from bioceramics play important roles for bone regeneration; however, it is unclear how each of ionic compositions in complex bioceramics exerts its specific effect on bone regeneration. The aim of present study is to elucidate the functional effects of Sr and Si ions in complex bioceramics on the regeneration of osteoporotic bone. A model bioceramic with Sr and Si-containing components (SMS) was successfully fabricated and the effects of ionic products from SMS bioceramics on the osteogenic, osteoclastic and angiogenic differentiation of rBMSCs-OVX and RANKL-induced osteoclasts were investigated. The results showed that SMS bioceramics could enhance ALP activity and expression of Col 1, OCN, Runx2 and angiogenic factors including VEGF and Ang-1. SMS bioceramics not only rebalanced the ratio of OPG/RANKL of OVX-BMSCs at early stage, but also repressed RANKL-induced osteoclast formation and expression of TRAP, DC-STAMP, V-ATPase a3, and NFATc1. The synergistic effects of Sr and Si ions were further investigated as compared with the similar concentration of Sr and Si ions alone. It was found that Sr and Si ions possessed synergistic effects on osteogenesis, osteoclastogenesis and angiogenesis, attributed to the dominant effects of Sr ions on enhancing angiogenesis and repressing osteoclastogenesis, and the dominant effects of Si ions on stimulating osteogenesis. The in vivo study using critical-size mandibular defects of OVX rat models showed that SMS bioceramics could significantly enhance bone formation and mineralization as compared with β-TCP bioceramics. It is suggested that SMS bioceramics may be a promising biomaterial for osteoporotic bone regeneration. To our knowledge, this is the first time to elucidate the specific effect of each ion from bioceramics on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration, paving the way to design functional biomaterials with complex compositions for tissue engineering and regenerative medicine.

    Topics: Alkaline Phosphatase; Animals; Biocompatible Materials; Bone Marrow Cells; Bone Regeneration; Cell Proliferation; Cell Survival; Female; Fluorescence; Ions; Mandible; Mice; Neovascularization, Physiologic; Osteoclasts; Osteogenesis; Osteoporosis; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Silicon; Strontium; Tartrate-Resistant Acid Phosphatase; X-Ray Microtomography

2017
Dietary silicon interacts with oestrogen to influence bone health: evidence from the Aberdeen Prospective Osteoporosis Screening Study.
    Bone, 2012, Volume: 50, Issue:3

    Silicon (Si), as Si(OH)(4), is derived mainly from plant-based foods. Dietary Si is associated with bone mineral density (BMD) in premenopausal but not postmenopausal women.. To examine the association between Si intake and markers of bone health in middle-aged women and to test for interaction with oestrogen status.. Femoral neck (FN) and lumbar spine (LS) BMD, urinary markers of bone resorption (free pyridinoline and deoxypyridinoline cross-links relative to creatinine, fPYD/Cr and fDPD/Cr) and serum markers of bone formation (N-terminal propeptide of type 1 collagen, P1NP) were measured in a cohort of 3198 women aged 50-62 years (n=1170 current HRT users, n=1018 never used HRT). Dietary Si, bioavailable Si and dietary confounders were estimated by food frequency questionnaire.. Mean FN BMD was 2% lower (p<0.005) in the lowest quartile (Q1) compared to the top quartile of energy-adjusted Si intake (Q4) (mean (SD) Q1, 16 (4.0) mg/d; Q4, 31.5 (7.3) mg/d). Energy-adjusted Si intake was associated with FN BMD for oestrogen-replete women only (late premenopausal women (r=+0.21, p=0.03); women on HRT [r=+0.09, p<0.001]). There was an interaction between oestrogen status and quartile of energy-adjusted Si intake on FN BMD, which was significant after adjustment for confounders (F=3.3, p=0.020), and stronger for bioavailable Si (F=5.0. p=0.002). Quartile of energy-adjusted dietary Si intake was negatively associated with fDPD/Cr and fPYD/Cr (p<0.001) and positively with P1NP (p<0.05).. This study suggests that oestrogen status is important for Si metabolism in bone health. Further work is required to elucidate the mechanism.

    Topics: Bone Density; Diet; Estrogens; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis; Silicon; Surveys and Questionnaires

2012
Anti-diabetic effects including diabetic nephropathy of anti-osteoporotic trace minerals on diabetic mice.
    Nutrition (Burbank, Los Angeles County, Calif.), 2011, Volume: 27, Issue:4

    In our previous study to evaluate the effects of soluble silicon (Si) on bone metabolism, Si and coral sand (CS) as a natural Si-containing material suppressed peroxisome proliferator-activated receptor γ (PPARγ), which regulates both glucose and bone metabolism and increases adipogenesis at the expense of osteogenesis, leading to bone loss. In this study, we investigated the anti-diabetic effects of bone-seeking elements, Si and stable strontium (Sr), and CS as a natural material containing these elements using obese diabetic KKAy mice.. Weanling male mice were fed diets containing 1% Ca supplemented with CaCO(3) as the control and CS, and diets supplemented with 50 ppm Si or 750 ppm Sr to control diet for 56 d. The mRNA expressions related to energy expenditure in the pancreas and kidney were quantified by real-time polymerase chain reaction.. At the end of feeding, plasma glucose, insulin, leptin, and adiponectin levels decreased significantly in three test groups, while pancreatic PPARγ and adiponectin mRNA expression levels increased significantly toward the normal level, improving the glucose sensitivity of β-cells and inducing a significant decrease in insulin expression. The renal PPARγ, PPARα, and adiponectin expression levels, histologic indices of diabetic glomerulopathy, and plasma indices of renal function were also improved significantly in the test groups.. Taken together, anti-osteoporotic trace minerals, Si and Sr, and CS containing them showed novel anti-diabetic effects of lowering blood glucose level, improving the tolerance to insulin, leptin, and adiponectin, and reducing the risk of glomerulopathy through modulation of related gene expression in the pancreas and kidney.

    Topics: Adiponectin; Animals; Biomarkers; Blood Glucose; Bone Density Conservation Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Supplements; Hypoglycemic Agents; Insulin; Kidney; Kidney Diseases; Kidney Glomerulus; Leptin; Male; Mice; Mice, Inbred Strains; Osteoporosis; Pancrelipase; PPAR gamma; Silicon; Silicon Compounds; Soil; Trace Elements

2011
Osteoporosis associated with pulmonary silicosis in an equine bone fragility syndrome.
    Veterinary pathology, 2011, Volume: 48, Issue:3

    California horses incur a bone fragility syndrome manifested by pathologic fractures. This study investigated gross, radiographic, and histologic features of the disorder as well as relationships with silicosis and levels of heavy metals and trace minerals through a postmortem study of 9 affected and 3 unaffected horses. Bones and soft tissues were evaluated grossly and histologically. Bones, lymph nodes, and lung tissue were evaluated radiographically. Tissues were evaluated for silicon levels, intracytoplasmic crystals, heavy metals, and trace minerals. All 9 affected horses had osteoporosis and clinical or subclinical pulmonary disease due to silicosis (8/9) or pneumoconiosis (1/9). All affected horses had radiographic findings consistent with osteopenia and histologic evidence of osteoporosis characterized by osteopenia, numerous resorption cavities, cement lines, and a mosaic lamellar pattern indicative of multiple remodeling events. Silicosis was characterized by widespread pulmonary granuloma formation with fibrosis; variable tracheobronchiolar and mediastinal granulomatous lymphadenitis; intracellular crystals within lung and lymph node macrophages; and pronounced lymph node fibrosis, focal necrosis, and dystrophic calcification. Crystals in lung (6/9) and lymph node (8/9) tissues were identified as cytotoxic silica dioxide polymorphs. Lung and liver tissue from affected horses had elevated levels of elemental silicon. Osteoporosis was highly correlated (r = 0.8, P < .01) with silicosis. No abnormalities in heavy metal or trace minerals were detected. This evaluation indicated that horses with bone fragility disorder have systemic osteoporosis associated with fibrosing pulmonary silicosis. The etiopathogenesis of the bone fragility syndrome is unknown; however, this study provides circumstantial evidence for a silicate associated osteoporosis.

    Topics: Animals; Bone and Bones; Bone Diseases, Metabolic; California; Female; Horse Diseases; Horses; Lung; Lymph Nodes; Male; Osteoporosis; Silicon; Silicosis

2011
Effects of beer, wine, and liquor intakes on bone mineral density in older men and women.
    The American journal of clinical nutrition, 2009, Volume: 89, Issue:4

    Moderate intake of alcohol has been reported to have beneficial effects on bone. However, different classes of alcoholic beverages have not been investigated.. Our aim was to determine the association between intake of total alcohol or individual alcoholic beverages and bone mineral density (BMD).. Adjusting for potential confounding factors, we examined alcohol intakes and BMD at 3 hip sites and the lumbar spine in 1182 men and in 1289 postmenopausal and 248 premenopausal women in the population-based Framingham Offspring cohort (age: 29-86 y).. Men were predominantly beer drinkers, and women were predominantly wine drinkers. Compared with nondrinkers, hip BMD was greater (3.4-4.5%) in men consuming 1-2 drinks/d of total alcohol or beer, whereas hip and spine BMD were significantly greater (5.0-8.3%) in postmenopausal women consuming >2 drinks/d of total alcohol or wine. Intake of >2 drinks/d of liquor in men was associated with significantly lower (3.0-5.2%) hip and spine BMD than was intake of 1-2 drinks/d of liquor in men. After adjustment for silicon intake, all intergroup differences for beer were no longer significant; differences for other alcohol sources remained significant. Power was low for premenopausal women, and the associations were not significant.. Moderate consumption of alcohol may be beneficial to bone in men and postmenopausal women. However, in men, high liquor intakes (>2 drinks/d) were associated with significantly lower BMD. The tendency toward stronger associations between BMD and beer or wine, relative to liquor, suggests that constituents other than ethanol may contribute to bone health. Silicon appears to mediate the association of beer, but not that of wine or liquor, with BMD. Other components need further investigation.

    Topics: Adult; Aged; Aged, 80 and over; Aging; Alcohol Drinking; Alcoholic Beverages; Beer; Bone Density; Cohort Studies; Cross-Sectional Studies; Diet; Dose-Response Relationship, Drug; Ethanol; Female; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Postmenopause; Premenopause; Risk Factors; Sex Factors; Silicon; Spine; Wine

2009
Biomechanical in vitro testing of human osteoporotic lumbar vertebrae following prophylactic kyphoplasty with different candidate materials.
    Spine, 2007, Jun-01, Volume: 32, Issue:13

    Biomechanical study of human osteoporotic lumbar vertebrae following prophylactic kyphoplasty.. To evaluate the potential benefits of different resorbable candidate materials for use in prophylactic kyphoplasty compared with the behavior of polymethylmethacrylate cement.. Kyphoplasty using PMMA bone cement for the stabilization of fractured osteoporotic vertebrae has been established as a useful clinical tool. In several studies, consecutive compression fractures have been reported in vertebrae caudal or cranial to those augmented with bone cement. Consequently, some physicians have begun to treat adjacent vertebrae by means of prophylactic augmentation.. Biomechanical in vitro testing was performed on 40 human osteoporotic nonfractured lumbar vertebrae. Three types of bone cement (PMMA, 2 different calcium phosphate cements) and one silicon derivative were assessed during compressive and cyclic sinusoidal testing. Each candidate material was applied bipedicularly under fluoroscopic control.. Differing processing qualities of the materials led to substantial differences during cement injection, in particular in the amount of cement filling of the vertebrae. However, in comparison to native vertebrae, augmented specimens showed significantly higher compressive failure. No significant differences between vertebral bodies treated with PMMA and those treated with either type of calcium phosphate cement were documented. The biomechanical properties of the vertebrae could not be significantly improved by the silicon derivative.. This study demonstrated that calcium phosphate cements displayed identical behavior to PMMA cement with respect to in vitro mechanical qualities. Consequently, from a mechanical viewpoint, calcium phosphate cements may be used in addition to PMMA cement for kyphoplasty and prophylactic kyphoplasty. Silicon derivatives are apparently not recommendable as candidate materials for kyphoplasty.

    Topics: Aged; Aged, 80 and over; Bone Cements; Calcium Phosphates; Compressive Strength; Female; Humans; In Vitro Techniques; Kyphosis; Lumbar Vertebrae; Male; Materials Testing; Middle Aged; Osteoporosis; Polymethyl Methacrylate; Silicon; Tomography, X-Ray Computed; Weight-Bearing

2007
[Avoid osteoporosis--eat silicon!].
    Ugeskrift for laeger, 2004, Sep-06, Volume: 166, Issue:37

    Topics: Bone Density; Diet; Female; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Silicon

2004
UK Food Standards Agency Optimal Nutrition Status Workshop: environmental factors that affect bone health throughout life.
    The British journal of nutrition, 2003, Volume: 89, Issue:6

    The UK Food Standards Agency (FSA) convened a group of expert scientists to discuss and review UK FSA- and Department of Health-funded research on diet and bone health. This research focused on the lifestyle factors that are amenable to change and may significantly affect bone health and the risk of osteoporotic fracture. The potential benefits of fruits and vegetables, meat, Ca, vitamins D and K and phyto-oestrogens were presented and discussed. Other lifestyle factors were also discussed, particularly the effect of physical activity and possible gene-nutrient interactions affecting bone health.

    Topics: Bone and Bones; Calcium; Consensus; Diet; Estrogens; Female; Fractures, Bone; Fruit; Humans; Male; Meat; Nutritional Physiological Phenomena; Nutritional Status; Osteoporosis; Phytotherapy; Plant Extracts; Silicon; Smoking; Sodium Chloride; Ultrasonography; United Kingdom; Vegetables; Vitamin D; Vitamin K

2003
Effect of silicon supplement on osteopenia induced by ovariectomy in rats.
    Calcified tissue international, 2000, Volume: 66, Issue:1

    The effect of silicon (Si) supplement on preventing bone mass loss induced by ovariectomy (OVX) in rats was investigated. Three groups of 15, 100-day-old female Wistar rats each, with a mean initial weight of approximately 260 g per animal, were selected for the present study. One of the experimental group consisting of 15 OVX rats was fed a diet supplemented with 500 mg of Si per kg of feed (Si + OVX). The other two groups consisting of 15 OVX and 15 sham-OVX rats did not receive these supplements. Morphometric (weight and length) and densitometric studies with dual-energy X-ray absorptiometry were performed on the whole femur and 5th lumbar vertebra of each animal 30 days after the experiment. The Si + OVX rats did not show a loss of bone mass induced by OVX at axial level (5th lumbar vertebra) or periphery (femur). Nonetheless, a significant increase (ANOVA with Bonferroni/Dunn post hocs test) of longitudinal development of the femur (P < 0.0001) was patent. These results, obtained through the measurements of axial and peripheral bones, warrant closer scrutiny in connection with the Si inhibitory effect on bone mass loss as well as the stimulatory effect on bone formation. Both actions, namely, inhibition of resorption and stimulation of formation, infer that Si may have a potential therapeutic application in the treatment of involutive osteoporosis.

    Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Development; Dietary Supplements; Female; Femur; Lumbar Vertebrae; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Silicon

2000
Dysregulation of trace element composition in ovariectomized cynomolgus monkey bones.
    Cellular and molecular biology (Noisy-le-Grand, France), 1998, Volume: 44, Issue:8

    One of the challenging issues in modern biomedical science is the increasing number of osteoporosis patients due to the expansion of elderly populations. Among aging-related pathogenic changes, alterations in bone function and skeletal pathogenesis is a particularly important issue of concern. Osteoporosis is one of the most serious bone-related pathogenic states, as it causes serious loss of quality of life. Alterations in estrogen levels in accordance with aging are one of the key risk factors for osteoporosis. Complexed estrogen actions on bones can be traced by analyzing bone mineral components, as those elements accumulate as mineral complexes, reflecting the context of multiple cellular reactions such as bone resorption/osteogenesis. We have analyzed bone trace element composition in ovariectomized (OVX-treated) Cynomolgus monkey models in this study. In order to gain insights into the effects of such defects on bone trace element composition, inductively coupled plasma atomic emissions spectrometry (ICP-AES) analysis was performed. Marked changes in bone trace element levels were found in vertebral bones of OVX-treated Cynomolgus monkeys. An assessment of these trace element spectra in OVX model animals is discussed. These results could provide useful markers for understanding the physiological states of bones in postmenopausal women.

    Topics: Animals; Body Weight; Bone Density; Calcium; Disease Models, Animal; Estradiol; Female; Macaca fascicularis; Magnesium; Osteoporosis; Ovariectomy; Ovary; Phosphorus; Silicon; Sodium; Spectrophotometry; Spine; Sulfur; Trace Elements; Zinc

1998
"Nutritional insurance" supplementation and corticosteroid toxicity.
    Medical hypotheses, 1982, Volume: 9, Issue:2

    Specialized "nutritional insurance" supplementation may reduce the risk of many important complications of long-term corticosteroid treatment. Supplementation with calcium, fluoride, activated vitamin D metabolites, and GTF, should help prevent osteoporosis. GTF, vitamin C, zinc and fluoride might help offset the inhibitory effect of corticosteroids on fibroblast and osteoblast function. Diabetic, hyperlipidemic and protein-losing effects might be compensated with supplementary GTF. Antioxidant nutrients could support humoral immunity and neutrophil function, while complementing the anti-inflammatory actions of corticosteroids. Supplementary magnesium could reduce the risk of nephrocalcinosis and nephrolithiasis.

    Topics: Adrenal Cortex Hormones; Amino Acids; Ascorbic Acid; Chromium; Diabetes Mellitus; Double-Blind Method; Fluorides; Food, Fortified; Humans; Hydroxycholecalciferols; Hyperlipidemias; Immunologic Deficiency Syndromes; Nephrocalcinosis; Nicotinic Acids; Nutritional Requirements; Osteoporosis; Selenium; Silicon

1982
[Silicon in the blood & arterial calcification].
    Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, 1957, Volume: 13, Issue:1-4

    Topics: Arteries; Calcification, Physiologic; Calcinosis; Humans; Osteoporosis; Silicon

1957